THE WOODLANDS, Texas and LONDON, Feb. 10, 2026 — Next Stage Trajectory, a Texas-based firm providing a 10X growth platform for founder-led companies at $1million in ARR, and Biodiversity Group Ltd, a London-based sustainability investment company, today announced the signing of a strategic agreement to create the Next Stage Fund. The Fund will be Texas-based and will be the first of several Funds to be created.

Under the terms of the collaboration, Biodiversity Group Ltd will provide an initial allocation of US $10 million. This will become the foundation for a growth capital funding for Next Stage Trajectory assets in Deep Tech and Emerging Technology.

Biodiversity Group Ltd will deliver independent technological verification using AI-driven monitoring, satellite data analysis, and blockchain-based traceability to validate project performance and ensure compliance with recognized sustainability disclosure frameworks.
Next Stage Trajectory will manage structuring, investment, and global placement, coordinating with financial intermediaries and regulatory stakeholders to facilitate transparent, compliant distribution to international capital markets.

“This agreement reinforces our commitment to easy access to growth capital for our Portfolio companies,” said Bill Weathersby, CEO of Next Stage Trajectory. “One of the biggest issues to 10X growth is access to capital, and our new Next Stage Fund solves that problem.”

“Our initial US $10 million allocation represents a meaningful step toward establishing liquidity and credibility in this emerging segment,” said Horacio Carvalho, CEO of Biodiversity Group Ltd. “The structure provides sustainable, compliant, and performance-backed opportunity to participate in Next Stage Trajectory portfolio companies.”

About Next Stage Trajectory
Next Stage Trajectory provides a 10X growth platform to founder-led companies at the $1 million ARR level. Headquartered in Houston, TX it has offices in the US, UK and EU.

About Biodiversity Group Ltd
Biodiversity Group Ltd is a UK-based investment firm specializing in biodiversity finance and sustainability-linked assets, focused on developing and distributing nature-positive financial instruments globally.

Media Contact
Press Office – Next Stage Trajectory
Email: [email protected]
Website: [https://nextstagetrajectory.com]

Press Office – Biodiversity Group Ltd
Email: [email protected]
Website: [www.biodiversitygroup.co.uk]

SOURCE Next Stage Trajectory

As AI accelerates how fast software is built, Force Equals is redefining how enterprises plan what to build — and why.

TAMPA, Fla., Feb. 10, 2026 — Force Equals, https://www.forceequals.ai/ an AI-native enterprise planning operating system, today announced it has raised a $2.2 million Series Seed round led by Cultivation Capital, with participation from prior investors.

The funding will be used to accelerate product development, expand go-to-market operations, and scale adoption of Force Equals’ AI Planning OS for enterprise software, AI, and business transformation initiatives. 

Enterprise organizations are facing a surge in software and AI-driven projects, along with the associated business transformation – all accelerated by generative AI and rapid development tooling. Yet planning processes remain fragmented, manual, and disconnected from execution.

Force Equals addresses this challenge with a multi-agent AI platform that transforms ideas into execution-ready plans by automatically mapping and collaborating with stakeholders, driving alignment, gathering critical context, generating functional, technical, and operational requirements, identifying risks and dependencies, managing approvals and project sign-offs, and producing delivery-ready artifacts for seamless handoff to downstream development, project management, and procurement workflows. Learn more at www.forceequals.ai .

As development velocity accelerates, planning and alignment have not kept pace. Without structured coordination of stakeholders and requirements, enterprises risk initiative bloat, execution chaos, and higher rates of failed transformation efforts.

Force Equals enables enterprise teams to answer the foundational questions that determine initiative success: what to prioritize, why it matters, whether the problem is fully understood, and whether the organization is ready to execute; ensuring delivery can begin with clarity and confidence. The platform activates across a portfolio of potential initiatives, helping organizations evaluate, prioritize, and align transformation investments at scale.

“Enterprise planning has become the critical bottleneck in transformation,” said Marc Chabot, Co-Founder & CEO of Force Equals. “Our platform compresses months of planning into minutes, aligns stakeholders automatically, and gives organizations confidence before delivery execution begins.”

“Force Equals is building foundational infrastructure for enterprise planning in the AI era,” said Paul Weber, General Partner at Cultivation Capital. “As organizations manage increasing complexity, their approach to planning must evolve. We’re excited to partner with the Force Equals team as they scale this emerging category.”

Since launching, Force Equals has gained traction among enterprise PMOs, IT leaders, and transformation teams seeking faster, more aligned planning for complex initiatives as they transition from managing tasks to orchestrating agent ecosystems – a shift Force Equals both enables for its customers and embodies through its own multi-agent platform architecture.  Enterprise teams can access and validate impact from the platform at  https://planner.forceequals.ai/

Force Equals is a platform that helps organizations plan their portfolio of complex software, AI, and business transformation initiatives. Its AI Planning Operating System, prioritizes for impact, orchestrates stakeholders, requirements, and agent-driven workflows, while seamlessly handing off to downstream execution systems.

Architected as a coordinated multi-agent platform, Force Equals enables enterprises and their project teams to evolve from managing tasks to orchestrating agent ecosystems across the planning lifecycle.

Learn more at www.forceequals.ai

SOURCE Force Equals Inc

Led by Run Ventures and backed by the Amazon Industrial Innovation Fund, Algorized scales the ‘Predictive Safety Engine’ to eliminate the “Safety vs. Speed” trade-off in industrial automation.

Algorized = The Nervous System for Physical AI

CAMPBELL, Calif. and ÉTOY, Switzerland, Feb. 10, 2026 — Algorized, the company building the intelligence layer for Physical AI, announced the close of a $13M Series A financing round led by Run Ventures, with participation from the Amazon Industrial Innovation Fund and Acrobator Ventures, as well as continued support from existing investors.

The investment scales the Predictive Safety Engine: a ground-up, edge-AI foundation models that enable Physical AI systems to perceive human presence, sense intent and adapt in real time. This capital accelerates the global rollout of a new standard in industrial robotics – moving the industry beyond “detect-and-stop” systems toward machines with true physical awareness.

The Economic Thesis: Physics, Not Pixels

The industry doesn’t need another sensor; it needs a nervous system. While generative AI has mastered language, Physical AI must master the world of people and objects. Algorized foundation models leverage existing infrastructure of wireless sensors such as Ultra-Wideband (UWB), mmWave, and Wi-Fi to digitize environments using physics, not pixels.

By analyzing micro-motions and vital signs directly at the edge, Algorized enables Physical AI to interpret human presence and intent with ultra-low latency. This allows robots to “see” through occlusion, dust, and darkness – navigating complex, shared human environments while eliminating unnecessary stops.

“The biggest bottleneck in Physical AI is the latency tax,” said Natalya Lopareva, CEO & Co-Founder of Algorized. “In a factory or a warehouse, a 100-millisecond delay can be the difference between a fluid workflow and a costly emergency stop. We’ve built an edge-native engine that gives machines the instinct to operate around people in real time. The goal is to ensure the line doesn’t stop because the intelligence is already there – on the floor, where it belongs.”

Scaling the ‘Aware Machine’

Following its breakthrough debut with KUKA and ASUS at CES 2026, Algorized is now deploying with major automotive and industrial leaders in Europe and the U.S. The Series A funding will focus on:

• Commercial Expansion: Scaling deliveries of the Predictive Safety Engine to meet signed demand across industries.
• Technical Sovereignty: Advancing proprietary intent-prediction models that serve as the foundation for human-robot collaboration.
• Global Operations: Expanding engineering and support hubs in Switzerland and Silicon Valley to serve Tier-1 manufacturing partners.

Investor Commentary

“Algorized is defining the category of Physical AI perception and predictive safety,” said PT Ungvichian, Partner at Run Ventures. “Most safety tech is an insurance policy; Algorized is a growth asset. By enabling robots to operate at full speed in shared spaces, they unlock billions in latent capacity. It’s rare to see a deep-tech solution with this level of immediate commercial ROI.”

About Algorized

Algorized builds the edge-native nervous system for Physical AI. Creators of the Predictive Safety Engine – ground-up edge-AI foundation models – Algorized transforms standard wireless sensors infrastructure into reliable human-aware perception. Backed by the Amazon Industrial Innovation Fund and rooted in Swiss research in through-wall human detection, Algorized is scaling globally through strategic partnerships with leading players across industrial robotics, automotive, and smart spaces – establishing a new standard for context-aware machines built for real-world operation. Learn more at www.algorized.com.

SOURCE Algorized

FULTON, Md., Feb. 10, 2026 — Tharros, a premier provider of mission-critical cybersecurity and vulnerability research solutions for the U.S. Federal Government, today announced a venture capital investment from Blue Delta Capital Partners, a Tysons, Virginia-based firm focused exclusively on the federal market.

Formerly known as ANALYGENCE, the company has rebranded as Tharros to better reflect its evolution into a proactive cyber-defense powerhouse. The brand change signals a commitment to helping government and defense agencies secure complex systems against an increasingly sophisticated threat landscape.

The investment from Blue Delta will provide Tharros with the capital and strategic runway to scale its technical capabilities, expand its roster of elite cyber experts, make tuck-in acquisitions, and accelerate the development of technology-led solutions that protect the nation’s most sensitive infrastructure and combat-ready systems.

“Blue Delta has an unmatched track record of supporting technology companies that thrive in the complex federal environment,” said Lonnie Parker, Founder and CEO of Tharros. “This partnership is about more than just capital; it’s about having the right strategic partners as we invest in our people and double down on innovation. Our goal is to ensure our customers can operate with total confidence to never allow cyber threats to stop the mission regardless of how the threat landscape shifts.”

Tharros bridges the gap between high-level cyber research and real-world operations. By combining deep domain expertise with cutting-edge R&D, the company identifies zero-day vulnerabilities and hardens systems at the speed of the mission.

“Tharros stands out because they aren’t just reacting to threats—they are fundamentally changing how federal agencies approach vulnerability,” said Kevin Robbins, General Partner of Blue Delta Capital Partners. “Lonnie and his team have built a differentiated platform with a clear vision for the future of government cybersecurity. We are excited to help them accelerate that growth, as non-control equity partners.”

About Tharros

Tharros boldly moves missions forward with advanced cybersecurity tools and deep vulnerability expertise that detect and eliminate threats before they emerge. Combining extensive cyber defense knowledge with the world’s preeminent vulnerability expertise, Tharros identifies and defends against attacks before they become problems. Working at mission speed, the company hardens mission systems faster and secures them for longer—ensuring agencies never lose the mission edge. By lifting the veil on enterprise cybersecurity to detect zero-day vulnerabilities before they have impact, Tharros enables mission maneuverability and the confidence to move missions forward. For more information, visit tharros.com

About Blue Delta Capital Partners

Blue Delta Capital Partners is a venture capital firm founded in 2009 and focused exclusively on the U.S. Federal Government market. The firm provides patient, flexible, non-control capital and strategic support to high-growth companies serving mission-critical government needs, partnering with founder-led teams to scale differentiated capabilities and drive long-term success. For more information, visit bluedeltacapitalpartners.com.

SOURCE Tharros

Natilus has attracted broad buy-in across defense, air freight and commercial aviation markets for the game changing economics that its blended-wing-body platform enables. Leveraging improved aerodynamics, capacity, and efficiency, its family of blended-wing aircraft cut fuel usage by 30% and carbon emissions and operational costs by 50%. This latest funding will allow Natilus to complete manufacturing of its first full-scale prototype of regional cargo plane KONA, which is expected to fly in the next 24 months. Natilus will also further invest in the development of its second aircraft, HORIZON EVO, a 200+-passenger aircraft intended to compete with the Boeing 737 MAX and Airbus A321-neo. Today, Natilus also debuted its transition from a single-deck to a dual-deck aircraft, implementing modifications to the profile and interior that substantially enhance passenger experience and safety.

Global aircraft demand has outpaced the combined production capabilities of Boeing and Airbus – leaving a shortfall of 15,000 planes that must be met over the next 20 years to satisfy global need. As a result, the market is hungry for a new manufacturing entrant that can navigate supply chain constraints and deliver a superior aircraft.

In the last 12 months, Natilus has made significant progress on its IP family and national manufacturing efforts. In July, it was awarded a patent for KONA’s diamond-shaped cargo bay and in March, it initiated the launch of its first domestic manufacturing site search to produce KONA. Currently, Natilus’s commercial product order book stands at 570+ aircraft, with reservations from major players like SpiceJet, Nolinor Aviation, Flexport, and Ameriflight – and is valued at $24 billion.

In addition to strong demand from domestic and global carriers, Natilus’s optionally-piloted KONA is gaining interest for its potential defense applications. With its 3.8 ton payload capacity and ability to land on shorter, gravel runways, KONA can provide intra-theater lift and transport cargo to remote locations more efficiently than ever before. The cargo freighter can support Agile Combat Employment (ACE) and logistics resupply in highly contested and austere regions such as the Indo-Pacific. Natilus has engaged in conversations with the U.S. Army, U.S. Air Force, and the Department of Defense, which see value in KONA.

“The aviation market is ripe for a new aircraft manufacturing entrant,” said Tim Draper, Founding Partner of Draper Associates. “Natilus’s innovative and technology-driven approach to developing blended wing aircraft has opened the doors for air freight and passenger airlines alike to embrace these new planes.”

Natilus has derisked the technology and expedited widespread commercial adoption by designing its planes to use existing engine technology and include vertical tails for control and stabilization. Natilus has designed its family of aircraft to be compatible with existing gate operations and airport infrastructure to maintain interoperability.

Meanwhile, Natilus is actively pursuing FAA Part 23, Amendment 64 certification for KONA and is determining a location for its 250,000 square feet manufacturing site to build 60 KONA per year. The company is on track to deliver the first KONA later this decade and the first HORIZON EVO in the early 2030s.

Natilus welcomes world-class aviation veteran and former Boeing executive, Kory Mathews, to the Natilus Board of Directors. During his tenure at Boeing, where he held positions as the VP of Phantom Works and VP and Chief Engineer of Boeing Military Aircraft, Kory led advanced aircraft design and rapid prototyping. He will leverage his experience there and now, as a Senior Partner at New Vista Capital, to provide valuable OEM and defense perspectives to the company.

“We’re not just building aircraft. We’re reshaping the future of aviation beyond the limitations of the tube-and-wing airframe to fundamentally transform how we transport goods and people,” said Aleksey Matyushev, Co-Founder and CEO of Natilus. “With this latest funding and newest personnel additions, we are strongly positioned to bring our family of blended-wing aircraft to market, disrupting the Boeing-Airbus duopoly and bringing much-needed innovation to the aviation industry.”

About Natilus
Natilus is a U.S.-based company developing a family of hyper-efficient blended-wing-body (BWB) aircraft designed to transport people and cargo more sustainably and efficiently than ever before. With over 570+ aircraft pre-orders valued at $24 billion, Natilus is commercializing its BWB aircraft that unlock improved aviation economics – reducing fuel consumption by 30% and operational costs by 50% while increasing payload capacity by 40%. Founded in 2016, the Natilus team is composed of innovators from Boeing, General Atomics, Northrop Grumman, Skunkworks, SpaceX, and Piper Aircraft. Learn more at natilus.co.

SOURCE Natilus

The funding will be used to scale Garner’s proprietary provider-ranking engine and incentive platform that now helps lower healthcare costs for over 2.5 million members

NEW YORK, Feb. 10, 2026 — Garner Health, a leading digital platform that helps patients find the best healthcare providers using better data and smarter financial incentives, announced it has raised $118 million in funding. Garner’s Series D, which brings the company’s total capital raised to-date to approximately $200 million, was led by Kleiner Perkins with participation from Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, Plus Capital, and other existing investors.

The funding comes at a time of explosive growth for Garner, with revenue up over 130% year-over-year as employers continue to look for alternatives to traditional provider search tools. The capital will be used to further expand Garner’s industry-leading doctor ranking platform, scale its AI-driven navigation and appointment booking capabilities and grow its team to meet the demands of a rapidly growing customer base.

The U.S. healthcare system suffers from a fundamental market failure: a lack of transparent data on physician quality and a lack of incentives for patients to seek high-performing providers.

“The single most important health decision we make is which individual doctor we see when we need care,” said Nick Reber, Founder and CEO of Garner Health. “Our data shows that the top-performing doctors have 75% lower rates of complications and mortality than their peers. By identifying these providers and creating the financial incentives for patients to see them, we aren’t just saving money—we’re fundamentally re-engineering the healthcare marketplace to reward quality.”

“Garner delivers a rare double win in healthcare: getting patients to the highest quality doctors while simultaneously cutting costs at scale,” said Josh Coyne at Kleiner Perkins. “Already serving 2.5 million people, Garner is fundamentally reshaping the way Americans access healthcare.”

Garner leverages one of the nation’s largest medical data sets – covering more than 320 million patient medical records – to identify doctors who follow the latest research, avoid unnecessary procedures, and help patients get healthy faster.

Unlike traditional transparency tools that fail to meaningfully change employees’ behavior, Garner drives true employee engagement. Garner does this by acting as a financial administrator that layers on top of existing health plans. When employees use Garner to find a Top Provider, their employer covers all or most out-of-pocket costs (deductibles and co-pays). The result: employees pay on average 80% less out-of-pocket to see the best doctors, while employers see an average 12% reduction in total healthcare spend in the first year alone.

Among Garner’s more than 700 clients and partners are some of the largest employers, health plans and providers in the country.

About Garner Health Garner Health is a health technology company on a mission to improve the quality of the American healthcare system. By using a massive dataset of 320 million patient records to identify the best doctors and creating powerful financial incentives for patients to see them, Garner helps employees get better care while significantly lowering costs for employers. For more information, visit www.garnerhealth.com.

Media Contact: [email protected]

SOURCE Garner Health Technology

CORK, Ireland, Feb. 10, 2026 — ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding round, to advance its lead program ITZ-DerMap™, a novel therapeutic designed for the treatment of onychomycosis (nail fungus).

€1.6 million of the round has now been secured, led by Lakeside Capital Ltd. Additional investors included Enterprise Ireland, The Boole Investment Syndicate and DeepIE Ventures. Sean Corkery, Director at Lakeside Capital Ltd, will join the ArrayPatch Board of Directors in conjunction with the investment. €0.3 million of previously issued convertible loan notes along with accrued interest also converted into equity in the company following the first close.

The new financing will enable ArrayPatch to accelerate the clinical development of ITZ-DerMap™, the first product emerging from its proprietary DerMap™ platform, towards clinical proof-of-concept. DerMap^TM is a pain-free microneedle patch comprising microscopic needles which are uniquely polymer-free and made entirely from the drug being delivered. On application of the patch, the microneedles penetrate the outer layer of skin, dissolve and release medication to the target site.  

“With this first close of our seed round secured, we are well-positioned to advance ITZ-DerMap™ into clinical development and bring a transformational treatment option to patients suffering from nail fungus,” said Dr. Waleed Faisal, Co-Founder and CEO of ArrayPatch.

“We are pleased to support ArrayPatch at this exciting early stage,” said Sean Corkery, Director at Lakeside Capital. “The team’s innovative approach to targeted drug delivery positions the company for a breakthrough clinical and commercial opportunity in multi-billion dollar global therapeutic markets.”

ArrayPatch Ltd was the winner of the InterTradeIreland all-island Seedcorn Investor Readiness Competition 2025, winner of the 2023 IDEATE Ireland competition and Innovation of the Year at the 2022 Irish Pharma Awards.

About ArrayPatch Ltd

ArrayPatch is a biotech company based in Cork, Ireland, developing next-generation microneedle-based therapeutics. Its DerMap™ platform harnesses polymer-free dissolving microneedles to deliver therapeutic agents directly to target tissues in a painless and efficient manner. The company’s lead program, ITZ-DerMap™, is designed to address the significant unmet medical need in onychomycosis (nail fungus), with additional applications under development for skin cancer, diabetes, weight loss and migraine. ArrayPatch was spun out from University College Cork and has secured significant non-dilutive funding and industry recognition to support its development strategy. For more information, please visit www.array-patch.com 

Contact:

Dr. Waleed Faisal
Founder, CEO
[email protected] 

Logo – https://mma.prnewswire.com/media/2889917/ArrayPatch.jpg

SOURCE ArrayPatch Ltd

SAN FRANCISCO, Feb. 10, 2026 — BotGauge AI, a US-headquartered Autonomous Quality-Assurance-as-a-Solution startup that owns software quality outcomes rather than selling tools, has raised $2 million in funding led by Surface Ventures (New York), with participation from IA Seed Ventures (Berkeley) and Saka Ventures (New York).

The company will use the capital to expand R&D, strengthen its autonomous agents, and scale across the US and other key markets.

AI-native development has accelerated software velocity, with code generated, iterated, and deployed at unprecedented speed. However, quality systems have not kept pace, creating a risk gap leading to production defects and higher post-release costs. Closing this gap requires QA to become autonomous and self-scaling, operating at the same speed as modern software development.

BotGauge AI is a managed Autonomous QA partner that takes ownership of software quality outcomes. Built on AI-powered agentic testing, its AI QA agents identify testing needs, generate and maintain comprehensive coverage, and execute tests at scale across the QA lifecycle, with validation from in-house QA domain experts. This enables engineering teams to focus on building and fixing defects while BotGauge owns quality execution, coverage, and release reliability.

BotGauge AI was founded by Pramin Pradeep, Naresh Kumar Rajendran, Vivek Nair, and Sreepad Krishnan Mavila, who bring over a decade of experience in AI-driven test automation and enterprise QA transformation. Their combined deep engineering expertise, interdisciplinary problem-solving, and product-first execution reimagine QA as core infrastructure for modern software development.

Speaking on the fundraise, Pramin Pradeep, Co-founder & CEO of BotGauge AI, said:
“We’re entering an era where AI redefines reliable, high-velocity software engineering. The real bottleneck today isn’t coding, it’s outdated QA that forces teams to trade speed for quality. Our autonomous agents own the quality lifecycle, test discovery, generation, maintenance, and execution, freeing engineers and experts to focus on innovation and customer impact. This funding accelerates our vision: making autonomous QA the unbreakable foundation for ambitious software organizations.”

A significant portion of the funding will support hiring across engineering, product, and AI to advance BotGauge from early adoption to an enterprise-ready, production-scale autonomous QA solution.

Commenting on the investment, Gyan Kapur, Co-Managing Partner at Surface Ventures, said, “Building autonomous QA for a diverse customer base requires solving complex organizational and technical problems. The BotGauge AI team has the background, intellect, and discipline to solve these problems over time. As a result, we are excited to partner with BotGauge AI as they redefine QA.”

Early deployments with customers including Sully.AI, OroLabs, Kitsa, and Ripple show 80% faster testing coverage, ~75% reduction in production bugs, and release cycles shortened by up to 50% without expanding QA teams.

Over the next 12–24 months, BotGauge AI plans to deepen engineering capabilities and expand adoption among mid-market and high-growth software companies globally. Long term, it aims to establish autonomous quality assurance as a foundational layer of modern software development, enabling faster releases with reliability and production confidence at scale.

Photo: https://mma.prnewswire.com/media/2890728/Botgauge_Cofounders.jpg

SOURCE Botgauge AI Private Limited

Midwest-based RIA steps into growth-stage capital leadership role typically held by coastal venture firms.

CHICAGO, Feb. 9, 2026 — ARENA Private Wealth, a Midwest-based registered investment advisor with offices in Chicago, Cleveland, and Columbus, today announced that it played the lead role in a $230 million Series B fundraising round for Positron AI, a growth-stage technology company building energy-efficient AI inference hardware. The round values Positron at over $1 billion, achieving unicorn status, and was announced at the Web Summit Qatar.

The Series B was led by ARENA Private Wealth alongside Jump Trading and Unless, with strategic investment from Qatar Investment Authority (QIA), Arm Holdings, and Helena, as well as participation from existing investors. Capital raises of this size and stature are most often led by technology-focused venture capital firms based on the coasts, making ARENA’s leadership role a notable departure from the traditional Series B playbook.

Rather than operating as a traditional venture capital firm, ARENA approaches growth-stage investing as an alternative capital partner. The firm positions itself as a bridge between private wealth and founders through an integrated platform spanning Private Wealth, Alternatives, and Capital Markets.

For ARENA’s investors, this model provides access to differentiated direct investment opportunities that are typically available only through large venture funds or institutional vehicles. Through ARENA’s relationships, diligence process, and ability to structure and lead transactions, investors can participate directly in opportunities like Positron, gaining exposure at a meaningful stage while remaining aligned with a disciplined, long-term approach to risk.

“Opportunities like this are rare, and that’s exactly why they can be so meaningful for our investors,” said Ari Schottenstein, Head of Alternatives at ARENA Private Wealth. “We say no far more often than we say yes, and when we do step forward, it’s because we’ve done the work to understand the risks and believe the opportunity justifies that responsibility. Positron stood out because the leadership, market position, and timing aligned in a way that allowed us to bring something truly differentiated to our clients.”

For founders, ARENA offers capital without competing interests and a fundraising option that operates outside traditional venture networks. In addition to capital, founders gain access to a broader and less homogeneous network, a strategic perspective informed by multiple markets and asset classes, and a collaborative partner focused on execution, alignment, and long-term value creation.

“As a founder, you’re used to thinking about venture firms and strategic investors as your primary options,” said Mitesh Agrawal, CEO of Positron AI. “What stood out about working with ARENA was their ability to show up as a true capital partner, bringing collaborative strategy, access to an expansive network of relationships, and a new perspective that helped us think differently about how we scale.”

“This investment reflects how growth-stage companies are opening the door to who they want at the table,” said Schottenstein. “Positron has shipping traction today and a credible roadmap ahead, and our role was to support that vision by showing up with broader investor support and alignment around long-term value creation.”

The Positron transaction marks an inflection point in the technology capital landscape, driven by rising investor interest in alternative investments. ARENA’s role illustrates how a modern private wealth firm can lead this next chapter as a relevant capital partner, stepping forward with conviction to source and shape opportunities, expanding the network of capital and ideas that support growth-stage companies.

About ARENA Private Wealth

ARENA Private Wealth is a Midwest-based wealth management firm offering an integrated platform across Private Wealth, Alternatives, and Capital Markets. With offices in Chicago, Cleveland, and Columbus, ARENA connects clients to differentiated opportunities through deep relationships, disciplined diligence, and a coordinated approach to long-term portfolio strategy. For more information, visit ARENApw.io.

SOURCE ARENA Private Wealth